Dermatology
(Die Seite wurde neu angelegt: „{{nc}}“) |
|||
(21 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) | |||
Zeile 1: | Zeile 1: | ||
− | {{ | + | {{pnc}} |
+ | {{ft|D}} | ||
+ | *'''[[Chilblains / acral lesions]]''' | ||
+ | *'''[[Dermatopathology]]''' | ||
+ | *'''[[Dermatology reviews and collections]]''' | ||
+ | |||
+ | {{tp|p=32294259|t=2020. A distinctive skin rash associated with Coronavirus Disease 2019 ?|pdf=|usr=}} | ||
+ | {{tp|p=32294270|t=2020. Viral exanthem in COVID-19, a clinical enigma with biological significance |pdf=|usr=}} | ||
+ | {{tp|p=32330336|t=2020. SARS-CoV-2 infection presenting as a febrile rash |pdf=|usr=}} | ||
+ | {{tp|p=32283235|t=ä. Various forms of skin rash in COVID-19 : a reply |pdf=|usr=}} | ||
+ | {{tp|p=32352486|t=2020. Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |pdf=|usr=}} | ||
+ | {{tp|p=32301221|t=2020. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | '''livedo reticularis''' | ||
+ | {{tp|p=32283229|t=ä. A dermatologic manifestation of COVID-19: Transient livedo reticularis |pdf=|usr=}} | ||
+ | |||
+ | '''petechial''' | ||
+ | {{tp|p=32352487|t=2020. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |pdf=|usr=}} | ||
+ | {{tp|p=32213305|t=2020. COVID-19 can present with a rash and be mistaken for dengue |pdf=|usr=}} | ||
+ | {{tp|p=32283233|t=ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | '''varicella-like''' | ||
+ | {{tp|p=32305439|t=ä. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients |pdf=|usr=}} | ||
+ | {{tp|p=32380215|t=ä. Reply to Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients?: discussing specificity |pdf=|usr=}} | ||
+ | {{tp|p=32315079|t=2020. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?|pdf=|usr=}} | ||
+ | |||
+ | '''morbilliform''' | ||
+ | {{tp|p=32313826|t=ä. Morbilliform exanthem associated with COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | '''urticaria-like''' | ||
+ | {{tp|p=32352022|t=2020. Urticarial exanthem as early diagnostic clue for COVID-19 infection |pdf=|usr=}} | ||
+ | {{tp|p=32329915|t=2020. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection |pdf=|usr=}} | ||
+ | {{tp|p=32294273|t=2020. Urticarial eruption in COVID-19 infection |pdf=|usr=}} | ||
+ | |||
+ | '''vesiculo-bullous''' | ||
+ | {{tp|p=32369674|t=2020. Oral vesiculobullous lesions associated with SARS-CoV-2 infection |pdf=|usr=}} | ||
+ | |||
+ | '''pemphigoid''' (as co-morbidity) | ||
+ | {{tp|p=32363963|t=2020. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report |pdf=|usr=}} | ||
+ | {{tp|p=32359182|t=2020. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus |pdf=|usr=}} | ||
+ | |||
+ | '''pernio''' | ||
+ | |||
+ | {{tp|p=32418860|t=ä. Lesiones cuteneas tipo perniosis durante la epidemia COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32402775|t=ä. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19 |pdf=|usr=}} | ||
+ | |||
+ | |||
+ | '''Pityriasis rosea''' | ||
+ | {{tp|p=32359180|t=2020. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection |pdf=|usr=}} | ||
+ | |||
+ | '''case reports''' | ||
+ | {{tp|p=32346588|t=ä. Dermatologic findings in two patients with COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32353170|t=2020. Cutaneous lesions in a patient with COVID-19: are they related?|pdf=|usr=}} | ||
+ | {{tp|p=32282312|t=2020. A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom |pdf=|usr=}} | ||
+ | {{tp|p=32358979|t=2020. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2) |pdf=|usr=}} | ||
+ | {{tp|p=32366113|t=2020. Foot Manifestations in a COVID-19 Positive Patient: A Case Study |pdf=|usr=}} | ||
+ | {{tp|p=32330339|t=2020. Cutaneous manifestation of COVID-19 in images: a case report |pdf=|usr=}} | ||
+ | {{tp|p=32330322|t=2020. Did Whatsapp reveal a new cutaneous COVID-19 manifestation?|pdf=|usr=}} | ||
+ | {{tp|p=32294264|t=2020. Cutaneous manifestations in COVID-19: a new contribution |pdf=|usr=}} | ||
+ | {{tp|p=32402385|t=ä. Manifestaciones cutaneas ... un caso |pdf=|usr=}} | ||
+ | |||
+ | ---- | ||
+ | {{tp|p=32420946|t=2020. COVID-19 and food allergy in children.|pdf=|usr=007}} | ||
+ | {{tp|p=32455505|t=2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.|pdf=|usr=007}} | ||
+ | {{tp|p=32344307|t=2020. COVID-19 type III hypersensitivity reaction |pdf=|usr=}} | ||
+ | {{tp|p=32455499|t=2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.|pdf=|usr=007}} | ||
+ | {{tp|p=32453902|t=2020. Chilblains-like lesions and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32445583|t=2020. Erythema multiforme-like lesions in children and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32484624|t=2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?|pdf=|usr=007}} | ||
+ | {{tp|p=32426864|t=2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.|pdf=|usr=007}} | ||
+ | {{tp|p=32421877|t=2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?|pdf=|usr=007}} | ||
+ | {{tp|p=32421876|t=2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32453865|t=2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32452545|t=2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.|pdf=|usr=007}} | ||
+ | {{tp|p=32452542|t=2020. COVID-19 Presenting with Atypical Sweet's Syndrome.|pdf=|usr=007}} | ||
+ | {{tp|p=32441876|t=2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32441830|t=2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32434277|t=2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32428303|t=2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.|pdf=|usr=007}} | ||
+ | {{tp|p=32428291|t=2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?|pdf=|usr=007}} | ||
+ | {{tp|p=32447761|t=2020. Dermatological findings in COVID-19 patients: Mexican experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32409442|t=2020. Skin manifestations of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32474947|t=2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32510648|t=2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?|pdf=|usr=007}} | ||
+ | {{tp|p=32500642|t=2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".|pdf=|usr=007}} | ||
+ | {{tp|p=32495400|t=2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?|pdf=|usr=007}} | ||
+ | {{tp|p=32495368|t=2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32491234|t=2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32491223|t=2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32488946|t=2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?|pdf=|usr=007}} | ||
+ | {{tp|p=32488910|t=2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.|pdf=|usr=007}} | ||
+ | {{tp|p=32497704|t=2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=007}} | ||
+ | {{tp|p=32496583|t=2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?|pdf=|usr=007}} | ||
+ | {{tp|p=32496578|t=2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.|pdf=|usr=007}} | ||
+ | {{tp|p=32495913|t=2020. Severe acute dried gangrene in COVID-19 infection: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32475035|t=2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32458546|t=2020. Cutaneous manifestations of COVID-19: A review of the published literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32447798|t=2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32438476|t=2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32421857|t=2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.|pdf=|usr=007}} | ||
+ | {{tp|p=32436736|t=2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32391713|t=2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?|pdf=|usr=007}} | ||
+ | {{tp|p=32441750|t=2020. Angioedema in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32500580|t=2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32506813|t=2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.|pdf=|usr=007}} | ||
+ | {{tp|p=32500647|t=2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.|pdf=|usr=007}} | ||
+ | {{tp|p=32460349|t=2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32479680|t=2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.|pdf=|usr=007}} | ||
+ | {{tp|p=32424886|t=2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.|pdf=|usr=007}} | ||
+ | {{tp|p=32418320|t=2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.|pdf=|usr=007}} | ||
+ | {{tp|p=32488318|t=2020. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.|pdf=|usr=008}} | ||
+ | {{tp|p=32442696|t=2020. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.|pdf=|usr=008}} | ||
+ | {{tp|p=32383189|t=2020. Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.|pdf=|usr=008}} | ||
+ | {{tp|p=32437936|t=2020. Viral exanthem with "Spins and needles sensation" on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner.|pdf=|usr=008}} | ||
+ | {{tp|p=32425356|t=2020. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?|pdf=|usr=008}} | ||
+ | {{tp|p=32502585|t=2020. CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC ("COVID TOES"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES.|pdf=|usr=008}} | ||
+ | {{tp|p=32534082|t=2020. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.|pdf=|usr=008}} | ||
+ | {{tp|p=32497698|t=2020. Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=008}} | ||
+ | {{tp|p=32305440|t=2020. Big data and cutaneous manifestations of COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32294262|t=2020. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.|pdf=|usr=008}} | ||
+ | {{tp|p=32386459|t=2020. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.|pdf=|usr=008}} | ||
+ | {{tp|p=32386448|t=2020. Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.|pdf=|usr=008}} | ||
+ | {{tp|p=32386447|t=2020. Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation.|pdf=|usr=008}} | ||
+ | {{tp|p=32386446|t=2020. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.|pdf=|usr=008}} | ||
+ | {{tp|p=32386442|t=2020. Localized mid-face miliaria as a consequence of filtering face piece respirator use during the COVID-19 pandemic.|pdf=|usr=008}} | ||
+ | {{tp|p=32422225|t=2020. Cutaneous Manifestations of COVID-19: A Preliminary Review.|pdf=|usr=008}} | ||
+ | {{tp|p=32417420|t=2020. Algorithm for the classification of COVID-19 rashes.|pdf=|usr=008}} | ||
+ | {{tp|p=32387668|t=2020. Reply to: "Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis".|pdf=|usr=008}} | ||
+ | {{tp|p=32387666|t=2020. Reply to: "A dermatologic manifestation of COVID-19: Transient livedo reticularis".|pdf=|usr=008}} | ||
+ | {{tp|p=32479979|t=2020. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries.|pdf=|usr=008}} | ||
+ | {{tp|p=32446827|t=2020. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions.|pdf=|usr=008}} | ||
+ | {{tp|p=32446824|t=2020. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions".|pdf=|usr=008}} | ||
+ | {{tp|p=32446821|t=2020. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign".|pdf=|usr=008}} | ||
+ | {{tp|p=32442700|t=2020. Reply to "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients": To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out.|pdf=|usr=008}} | ||
+ | {{tp|p=32442697|t=2020. Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out".|pdf=|usr=008}} | ||
+ | {{tp|p=32450058|t=2020. Paniculitis eosinofilica secundaria a infeccion por COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32401723|t=2020. COVID-19 y piel.|pdf=|usr=008}} | ||
+ | {{tp|p=32387155|t=2020. Digital Ischemia in COVID-19 Patients: Case Report.|pdf=|usr=008}} | ||
+ | {{tp|p=32409976|t=2020. Follow-up of skin lesions during the evolution of COVID-19: a case report.|pdf=|usr=008}} | ||
+ | {{tp|p=32533844|t=2020. Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.|pdf=|usr=008}} | ||
+ | {{tp|p=32456878|t=2020. Lesiones cutaneas en paciente con infeccion por SARS-COV-2.|pdf=|usr=008}} | ||
+ | {{tp|p=32389502|t=2020. Manifestaciones cutaneas en contexto del brote actual de enfermedad por coronavirus 2019.|pdf=|usr=008}} | ||
+ | {{tp|p=32464157|t=2020. Cutaneous hyperesthesia: A novel manifestation of COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32530130|t=2020. An unilateral purpuric rash in a patient with COVID-19 infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32472593|t=2020. Cutaneous manifestations in COVID-19: a skin rash in a child.|pdf=|usr=008}} | ||
+ | {{tp|p=32520428|t=2020. Mucosal involvement in a COVID-19-positive patient: a case report.|pdf=|usr=008}} | ||
+ | |||
+ | {{tp|p=32531120|t=2020. Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.|pdf=|usr=008}} | ||
+ | {{tp|p=32526040|t=2020. The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases.|pdf=|usr=008}} | ||
+ | {{tp|p=32525251|t=2020. Urticaria (angioedema) and COVID- 19 infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32526051|t=2020. Acute maculopapular eruption in Covid-19 patient: a case report.|pdf=|usr=008}} | ||
+ | |||
+ | {{tp|p=32535979|t=2020. The red half moon nail sign: a novel manifestation of Coronavirus infection.|pdf=|usr=008}} | ||
+ | {{tp|p=32535943|t=2020. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.|pdf=|usr=008}} | ||
+ | {{tp|p=32534473|t=2020. "COVID-19-related acute genital ulcers".|pdf=|usr=008}} | ||
+ | {{tp|p=32534469|t=2020. Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization.|pdf=|usr=008}} | ||
+ | {{tp|p=32533899|t=2020. Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.|pdf=|usr=008}} | ||
+ | {{tp|p=32531860|t=2020. Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description.|pdf=|usr=008}} | ||
+ | {{tp|p=32531121|t=2020. Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology.|pdf=|usr=008}} | ||
+ | {{tp|p=32531119|t=2020. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32455090|t=2020. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).|pdf=|usr=008}} | ||
+ | {{tp|p=32385858|t=2020. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.|pdf=|usr=008}} | ||
+ | {{tp|p=32384180|t=2020. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.|pdf=|usr=008}} | ||
+ | {{tp|p=32407564|t=2020. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.|pdf=|usr=008}} | ||
+ | {{tp|p=32356578|t=2020. Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32383234|t=2020. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.|pdf=|usr=008}} | ||
+ | {{tp|p=32524630|t=2020. Rash as a presenting complaint in a child with COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32533607|t=2020. Chilblains in children in the time of Covid-19: new evidence with serology assay.|pdf=|usr=008}} | ||
+ | {{tp|p=32401411|t=2020. A case of COVID-19 pneumonia presenting with acute urticaria.|pdf=|usr=008}} | ||
+ | {{tp|p=32390279|t=2020. Cutaneous signs in COVID-19 patients: A review.|pdf=|usr=008}} | ||
+ | {{tp|p=32445283|t=2020. Atypical erythema nodosum in a patient with COVID-19 pneumonia.|pdf=|usr=008}} | ||
+ | {{tp|p=32445279|t=2020. Diagnostic and prognostic values of cutaneous manifestations in COVID-19.|pdf=|usr=008}} | ||
+ | {{tp|p=32424851|t=2020. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.|pdf=|usr=008}} | ||
+ | {{tp|p=32412681|t=2020. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations.|pdf=|usr=008}} | ||
+ | {{tp|p=32385869|t=2020. Coronavirus Disease-2019 with Dermatologic Manifestations and Implications: An Unfolding Conundrum.|pdf=|usr=008}} | ||
+ | {{tp|p=32410241|t=2020. Skin involvement in SARS-CoV-2 infection: Case series.|pdf=|usr=008}} | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | {{tp|p=32385938|t=2020. A dermatologist's perspective of the COVID-19 outbreak.|pdf=|usr=008}} |
Aktuelle Version vom 12. September 2020, 17:23 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
D further streaming-in related content is here
32294259 2020. A distinctive skin rash associated with Coronavirus Disease 2019 ?
32294270 2020. Viral exanthem in COVID-19, a clinical enigma with biological significance
32330336 2020. SARS-CoV-2 infection presenting as a febrile rash
32283235 ä. Various forms of skin rash in COVID-19 : a reply
32352486 2020. Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
32301221 2020. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity
livedo reticularis
32283229 ä. A dermatologic manifestation of COVID-19: Transient livedo reticularis
petechial
32352487 2020. Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
32213305 2020. COVID-19 can present with a rash and be mistaken for dengue
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection
varicella-like
32305439 ä. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients
32380215 ä. Reply to Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients?: discussing specificity
32315079 2020. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?
morbilliform
32313826 ä. Morbilliform exanthem associated with COVID-19
urticaria-like
32352022 2020. Urticarial exanthem as early diagnostic clue for COVID-19 infection
32329915 2020. Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection
32294273 2020. Urticarial eruption in COVID-19 infection
vesiculo-bullous
32369674 2020. Oral vesiculobullous lesions associated with SARS-CoV-2 infection
pemphigoid (as co-morbidity)
32363963 2020. Mucous membrane pemphigoid and COVID-19 treated with high-dose intravenous immunoglobulins: a case report
32359182 2020. Occurrence of SARS-CoV-2 during mycophenolate mofetil treatment for pemphigus
pernio
32418860 ä. Lesiones cuteneas tipo perniosis durante la epidemia COVID-19
32402775 ä. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19
Pityriasis rosea
32359180 2020. Pityriasis rosea as a cutaneous manifestation of COVID-19 infection
case reports
32346588 ä. Dermatologic findings in two patients with COVID-19
32353170 2020. Cutaneous lesions in a patient with COVID-19: are they related?
32282312 2020. A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom
32358979 2020. Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2)
32366113 2020. Foot Manifestations in a COVID-19 Positive Patient: A Case Study
32330339 2020. Cutaneous manifestation of COVID-19 in images: a case report
32330322 2020. Did Whatsapp reveal a new cutaneous COVID-19 manifestation?
32294264 2020. Cutaneous manifestations in COVID-19: a new contribution
32402385 ä. Manifestaciones cutaneas ... un caso
32420946 2020. COVID-19 and food allergy in children.
32455505 2020. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
32344307 2020. COVID-19 type III hypersensitivity reaction
32455499 2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.
32453902 2020. Chilblains-like lesions and COVID-19.
32445583 2020. Erythema multiforme-like lesions in children and COVID-19.
32484624 2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?
32426864 2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.
32421877 2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?
32421876 2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
32453865 2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).
32452545 2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
32452542 2020. COVID-19 Presenting with Atypical Sweet's Syndrome.
32441876 2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.
32441830 2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.
32434277 2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.
32428303 2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.
32428291 2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?
32447761 2020. Dermatological findings in COVID-19 patients: Mexican experience.
32409442 2020. Skin manifestations of COVID-19.
32474947 2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
32510648 2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?
32500642 2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".
32495400 2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?
32495368 2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.
32491234 2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.
32491223 2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.
32488946 2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?
32488910 2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.
32497704 2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
32496583 2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
32496578 2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
32495913 2020. Severe acute dried gangrene in COVID-19 infection: a case report.
32475035 2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.
32458546 2020. Cutaneous manifestations of COVID-19: A review of the published literature.
32447798 2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?
32438476 2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.
32421857 2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.
32436736 2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.
32391713 2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
32441750 2020. Angioedema in COVID-19.
32500580 2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.
32506813 2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.
32500647 2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.
32460349 2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
32479680 2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.
32424886 2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
32418320 2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.
32488318 2020. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms.
32442696 2020. Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy.
32383189 2020. Re: Chilblain-like lesions on feet and hands during the COVID-19 pandemic.
32437936 2020. Viral exanthem with "Spins and needles sensation" on extremities of a COVID-19 patient: A self-reported case from an Indonesian medical frontliner.
32425356 2020. Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
32502585 2020. CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC ("COVID TOES"): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES.
32534082 2020. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
32497698 2020. Reply to: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
32305440 2020. Big data and cutaneous manifestations of COVID-19.
32294262 2020. Comment on: Cutaneous manifestations in COVID-19: a first perspective. Safety concerns of clinical images and skin biopsies.
32386459 2020. Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient.
32386448 2020. Acute Generalized Exanthematous Pustulosis with Erythema Multiforme-Like lesions in a COVID-19 woman.
32386447 2020. Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation.
32386446 2020. Atypical erythema multiforme palmar plaques lesions due to Sars-Cov-2.
32386442 2020. Localized mid-face miliaria as a consequence of filtering face piece respirator use during the COVID-19 pandemic.
32422225 2020. Cutaneous Manifestations of COVID-19: A Preliminary Review.
32417420 2020. Algorithm for the classification of COVID-19 rashes.
32387668 2020. Reply to: "Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis".
32387666 2020. Reply to: "A dermatologic manifestation of COVID-19: Transient livedo reticularis".
32479979 2020. Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries.
32446827 2020. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions.
32446824 2020. Comment on: "Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acro-ischemic lesions".
32446821 2020. Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign".
32442700 2020. Reply to "Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients": To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out.
32442697 2020. Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out".
32450058 2020. Paniculitis eosinofilica secundaria a infeccion por COVID-19.
32401723 2020. COVID-19 y piel.
32387155 2020. Digital Ischemia in COVID-19 Patients: Case Report.
32409976 2020. Follow-up of skin lesions during the evolution of COVID-19: a case report.
32533844 2020. Sars-CoV-2 infection: the same virus can cause different cutaneous manifestations.
32456878 2020. Lesiones cutaneas en paciente con infeccion por SARS-COV-2.
32389502 2020. Manifestaciones cutaneas en contexto del brote actual de enfermedad por coronavirus 2019.
32464157 2020. Cutaneous hyperesthesia: A novel manifestation of COVID-19.
32530130 2020. An unilateral purpuric rash in a patient with COVID-19 infection.
32472593 2020. Cutaneous manifestations in COVID-19: a skin rash in a child.
32520428 2020. Mucosal involvement in a COVID-19-positive patient: a case report.
32531120 2020. Histological findings in chilblain-lupus like COVID lesions: in search of an answer to understand their etiology.
32526040 2020. The broad spectrum of dermatological manifestations in COVID-19. Clinical and histopathological features learned from a series of 34 cases.
32525251 2020. Urticaria (angioedema) and COVID- 19 infection.
32526051 2020. Acute maculopapular eruption in Covid-19 patient: a case report.
32535979 2020. The red half moon nail sign: a novel manifestation of Coronavirus infection.
32535943 2020. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach.
32534473 2020. "COVID-19-related acute genital ulcers".
32534469 2020. Cutaneous manifestations of hospitalized COVID-19 patients: A report of six cases with clinicopathologic features and viral RNA in situ hybridization.
32533899 2020. Major cluster of pediatric " true " primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
32531860 2020. Papular-Purpuric Exanthem in a COVID-19 Patient: Clinical and Dermoscopic Description.
32531121 2020. Two cases of cutaneous eruptions due to CoVID-19 infection in Singapore: New insights into the spectrum of clinical presentation and histopathology.
32531119 2020. A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19.
32455090 2020. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).
32385858 2020. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological findings.
32384180 2020. Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital.
32407564 2020. Cutaneous manifestations in COVID-19: familial cluster of urticarial rash.
32356578 2020. Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.
32383234 2020. Cutaneous manifestations of the Coronavirus Disease 2019 (COVID-19): A brief review.
32524630 2020. Rash as a presenting complaint in a child with COVID-19.
32533607 2020. Chilblains in children in the time of Covid-19: new evidence with serology assay.
32401411 2020. A case of COVID-19 pneumonia presenting with acute urticaria.
32390279 2020. Cutaneous signs in COVID-19 patients: A review.
32445283 2020. Atypical erythema nodosum in a patient with COVID-19 pneumonia.
32445279 2020. Diagnostic and prognostic values of cutaneous manifestations in COVID-19.
32424851 2020. Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age. Case report.
32412681 2020. Appearance of skin rash in pediatric patients with COVID-19: Three case presentations.
32385869 2020. Coronavirus Disease-2019 with Dermatologic Manifestations and Implications: An Unfolding Conundrum.
32410241 2020. Skin involvement in SARS-CoV-2 infection: Case series.
32385938 2020. A dermatologist's perspective of the COVID-19 outbreak.